OPENLANE, Inc.

OPLN

Held by 1 specialist biotech fund

Share on X

Fund Holdings

Driehaus Capital

AI Signal

AI analyst context — unlock full analysis

Catalysts

No catalysts tracked.

Position Details

Driehaus CapitalNEWFeb 17, 2026

Shares: 588,120Value: $17.5M

# Signal Note: Driehaus Capital Initiates OPLN Position **Summary:** Growth-focused Driehaus Capital established a $17.5M stake in OPENLANE (588K shares), signaling conviction in the company's commercial execution or pipeline trajectory. OPLN operates in vehicle logistics/auction services—this appears to be a non-biotech holding, suggesting either a data error or portfolio diversification move inconsistent with Driehaus's typical biotech focus. **Caveat:** Verify OPLN's current business segment; if recently pivoted to biotech/medtech, clarify the therapeutic area and nearest clinical/regulatory catalysts driving institutional entry.

Know which insider moves are real

See who's buying with their own money vs. routine exercises
AI explains why each move matters right now

Start 7-Day Free Trial — $29/mo

Insider Signals

No insider signals tracked.

Also Held by These Funds

PTN1 fund WLDN1 fund LASR1 fund ONTO1 fund VALE1 fund TNDM1 fund TKO1 fund TNL1 fund

Research Links

Yahoo Finance →SEC EDGAR →ClinicalTrials.gov →

Track specialist biotech funds, insider signals, and AI analysis

Start 7-Day Free Trial

Or get the free weekly brief: